Suddenly stopping long-term preventive treatment with danazol — a hormone therapy being phased out in hereditary angioedema (HAE)…
Articles by Margarida Maia, PhD
The first adult participant with hereditary angioedema (HAE) has been dosed in STOP-HAE, a Phase 3 clinical trial evaluating…
A man in the U.S. developed nonallergic angioedema on his tongue after he ran out of his blood-pressure medication…
Biocryst Pharmaceuticals is preparing to acquire Astria Therapeutics, and with it navenibart, a still-experimental, long-acting prophylactic (preventive) treatment…
Haloperidol, an antipsychotic medication commonly used to treat schizophrenia and severe agitation, was behind a rare case of angioedema…
The U.S. Food and Drug Administration (FDA) has approved Andembry (garadacimab-gxii) to prevent swelling attacks caused by hereditary…
The use of the antibody navenibart, being developed by Astria Therapeutics to prevent swelling episodes in …
Keeping symptoms of hereditary angioedema (HAE) under control is the most important factor contributing to a better quality of…
More than half of individuals admitted to an emergency department, or ED, for drug-induced nonallergic angioedema — with nearly…
Sebetralstat, an oral small molecule being developed by Kalvista Pharmaceuticals, provided adults and adolescents with hereditary angioedema…